Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

View ORCID ProfileEleanor L. Watts, View ORCID ProfileTomas I. Gonzales, Tessa Strain, Pedro F. Saint-Maurice, D. Timothy Bishop, Stephen J. Chanock, Mattias Johansson, Temitope O. Keku, Loic Le Marchand, Victor Moreno, Polly A. Newcomb, Christina C. Newton, Rish K. Pai, The PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS, Mark P. Purdue, Cornelia M. Ulrich, Karl Smith-Byrne, Bethany Van Guelpen, Felix R. Day, Katrien Wijndaele, Nicholas J. Wareham, Charles E. Matthews, Steven C. Moore, Soren Brage
doi: https://doi.org/10.1101/2023.03.28.23287805
Eleanor L. Watts
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eleanor L. Watts
  • For correspondence: eleanor.watts{at}nih.gov
Tomas I. Gonzales
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tomas I. Gonzales
Tessa Strain
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro F. Saint-Maurice
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Timothy Bishop
3Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen J. Chanock
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattias Johansson
4Genomics Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Temitope O. Keku
5Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loic Le Marchand
6University of Hawaii Cancer Center, Honolulu, Hawaii, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Moreno
7Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
8CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
9Department of Clinical Sciences, Faculty of Medicine and Univeristy of Barcelona Institute for Complex Systems (UBICS), University of Barcelona, Barcelona, Spain
10ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polly A. Newcomb
11Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
12School of Public Health, University of Washington, Seattle, Washington, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina C. Newton
13Department of Population Science, American Cancer Society, Atlanta, Georgia, USA
MS, PH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rish K. Pai
14Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark P. Purdue
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelia M. Ulrich
15Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Smith-Byrne
16Nuffield Department of Population Health, University of Oxford, Oxford, UK
DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bethany Van Guelpen
17Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden
18Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix R. Day
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrien Wijndaele
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J. Wareham
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
MBBS, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles E. Matthews
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven C. Moore
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soren Brage
2MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge, Cambridge, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance The association of cardiorespiratory fitness with cancer risk is not clear.

Objective To investigate whether fitness is associated with the risk of diagnosis of common cancers.

Design, setting, and participants In observational analyses, we used multivariable-adjusted Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of cancer in a subset of UK Biobank participants who completed a submaximal fitness test in 2009-12 (N=72,572). In secondary analyses, we used a two-sample Mendelian randomization (MR) framework, with genetically predicted fitness as an instrumental variable derived from UK Biobank study participants and genetic cancer data from international consortia. Odds ratios (ORs) were estimated using the inverse-variance weighted method.

Relationships between fitness and cancer may be partially mediated by adiposity, and therefore associations were estimated with and without adjustment for adiposity.

Exposures Estimated maximal cardiorespiratory fitness (ml O2⋅min-1⋅kg-1 total-body mass and ml O2⋅min-1⋅kg-1 fat-free mass).

Main outcomes and measures Diagnosis of lung, colon, rectal, endometrial, female breast, and prostate cancer. MR analyses additionally included pancreatic and renal cancers.

Results After a median of 11 years of follow-up, 4,290 cancers of interest were diagnosed. A 3.5 ml O2⋅min-1⋅kg-1 total-body mass increase in fitness (approximately 0.5 standard deviation (SD)) was associated with lower risks of endometrial (HR=0.81, 95% CI 0.73-0.89), colorectal (0.94, 0.90-0.99), and breast cancer (0.96, 0.92-0.99). In MR analyses, higher levels of genetically predicted fitness were associated with a lower risk of breast cancer (OR per genetically predicted 0.5 SD increase in ml O2⋅min-1⋅kg-1 fat-free mass=0.92, 95% CI 0.86-0.98), including estrogen receptor (ER)+ (0.91, 0.84-0.99) and ER-(0.88, 0.80-0.97) subtypes. After adjusting for body fat, both the observational and genetic associations were attenuated.

Conclusions and relevance Higher fitness levels may reduce risks of endometrial, colorectal, and breast cancer, though relationships with adiposity are complex and may mediate these relationships. Aiming to increase fitness, including via changes in body composition, may be an effective strategy for cancer prevention.

KEY POINTS Question: Is cardiorespiratory fitness associated with subsequent risk of cancer diagnosis?

Findings: In a prospective cohort study of 73,000 cancer-free participants who completed a submaximal fitness test, we report that higher fitness levels were associated with lower risks of endometrial, colorectal, and breast cancer. Using two-sample Mendelian randomization methods we also found an inverse association with breast cancer. Associations were attenuated following adjustment for adiposity.

Meaning: Higher fitness may be associated with reduced risk of certain cancer sites. Aiming to increase fitness, including via changes in body composition, may be an effective strategy for cancer prevention. The role of adiposity in mediating the relationship between fitness and cancer risk is not fully understood, and further research is needed to explore this complex relationship.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

EW, SM, CM, PSM are supported by the Intramural Research Program of the National Institutes of Health (NIH). NW, TS, FRD, KW, TG and SB are supported by UK Medical Research Council [grant numbers MC_UU_00006/1, MC_UU_00006/2 and MC_UU_00006/4]. NW and SB are supported by the NIHR Biomedical Research Centre in Cambridge (IS-BRC-1215-20014). The NIHR Cambridge Biomedical Research Centre (BRC) is a partnership between Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge, funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank had obtained ethics approval from the North West Multi-centre Research Ethics Committee which covers the UK (approval number: 11/NW/0382) and had obtained informed consent from all participants. The UK Biobank approved an application for use of the data (ID 408 and 9905)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵+ Joint senior authors

  • ↵‡ Members from the PRACTICAL Consortium, CRUK, BPC3, CAPS and PEGASUS are provided in Appendix 1.

Data Availability

The UK Biobank is an open-access resource and bona fide researchers can apply to use the UK Biobank dataset by registering and applying at http://ukbiobank.ac.uk/register-apply/. Further information is available from the corresponding author upon request. For genetic cancer data, summary GWAS statistics are publicly available for breast (https://bcac.ccge.medschl.cam.ac.uk/), endometrial (https://www.ebi.ac.uk/gwas/studies/GCST006464), ovarian (https://ocac.ccge.medschl.cam.ac.uk) and prostate (overall only) (http://practical.icr.ac.uk/). Data for renal cell carcinoma and pancreatic cancer were accessed via dbGaP; Study Accession: phs000206.v3.p2 and phs000648.v1.p1; project reference 9314 (https://www.ncbi.nlm.nih.gov/gap/). Summary genetic data for aggressive prostate cancer (http://practical.icr.ac.uk/), lung cancer (https://ilcco.iarc.fr/) and colorectal cancer (https://research.fredhutch.org/peters/en/genetics-and-epidemiology-of-colorectal-cancer-consortium.html) are not currently publicly available but may be made available upon application, see respective websites for details.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted March 30, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
Eleanor L. Watts, Tomas I. Gonzales, Tessa Strain, Pedro F. Saint-Maurice, D. Timothy Bishop, Stephen J. Chanock, Mattias Johansson, Temitope O. Keku, Loic Le Marchand, Victor Moreno, Polly A. Newcomb, Christina C. Newton, Rish K. Pai, The PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS, Mark P. Purdue, Cornelia M. Ulrich, Karl Smith-Byrne, Bethany Van Guelpen, Felix R. Day, Katrien Wijndaele, Nicholas J. Wareham, Charles E. Matthews, Steven C. Moore, Soren Brage
medRxiv 2023.03.28.23287805; doi: https://doi.org/10.1101/2023.03.28.23287805
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
Eleanor L. Watts, Tomas I. Gonzales, Tessa Strain, Pedro F. Saint-Maurice, D. Timothy Bishop, Stephen J. Chanock, Mattias Johansson, Temitope O. Keku, Loic Le Marchand, Victor Moreno, Polly A. Newcomb, Christina C. Newton, Rish K. Pai, The PRACTICAL consortium, CRUK, BPC3, CAPS, PEGASUS, Mark P. Purdue, Cornelia M. Ulrich, Karl Smith-Byrne, Bethany Van Guelpen, Felix R. Day, Katrien Wijndaele, Nicholas J. Wareham, Charles E. Matthews, Steven C. Moore, Soren Brage
medRxiv 2023.03.28.23287805; doi: https://doi.org/10.1101/2023.03.28.23287805

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)